Mclaren PJ, Carrington M. The impact of host genetic variation on infection with HIV-1. Nat Immunol. 2015;16:577–83.
Article CAS PubMed PubMed Central Google Scholar
Fraser C, Lythgoe K, Leventhal GE, Shirreff G, Hollingsworth TD, Alizon S, et al. Virulence and pathogenesis of HIV-1 infection: An evolutionary perspective. Science. 2014;343(6177):1–18.
McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, et al. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci. 2015;112(47):14658–63. https://doi.org/10.1073/pnas.1514867112.
Article CAS PubMed PubMed Central Google Scholar
Gabrielaite M, Bennedbæk M, Zucco AG, Ekenberg C, Murray DD, Kan VL, et al. Human immunotypes impose selection on viral genotypes through viral epitope specificity. J Infect Dis. 2021;224(12):2053–63.
Article CAS PubMed PubMed Central Google Scholar
Marmor M, Hertzmark K, Thomas SM, Halkitis PN, Vogler M. Resistance to HIV infection. J Urban Heal. 2006;83(1):5–17.
Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 2009;5(12):e1000791.
Article PubMed PubMed Central Google Scholar
McLaren PJ, Pulit SL, Gurdasani D, Bartha I, Shea PR, Pomilla C, et al. Evaluating the impact of functional genetic variation on HIV-1 control. J Infect Dis. 2017;216(9):1063–9.
Article CAS PubMed PubMed Central Google Scholar
Tough RH, McLaren PJ. Interaction of the host and viral genome and their influence on HIV disease. Front Genet. 2019;10:1–9.
Ohainle M, Helms L, Vermeire J, Roesch F, Humes D, Basom R, et al. A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife. 2018;7:1–32.
Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet. 2010;11(12):843–54.
Article CAS PubMed Google Scholar
Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591(7848):92–8.
Al QZ, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:4570.
Diop G, Hirtzig T, Do H, Coulonges C, Vasilescu A, Labib T, et al. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomed Pharmacother. 2006;60(9):569–77.
Article CAS PubMed Google Scholar
Sandstrom TS, Ranganath N, Angel JB. Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication. Cytokine Growth Factor Rev. 2017;2017(37):1–16.
Soper A, Kimura I, Nagaoka S, Konno Y, Yamamoto K, Koyanagi Y, et al. Type i interferon responses by HIV-1 infection: association with disease progression and control. Front Immunol. 2018;5(8):1–11. https://doi.org/10.3389/fimmu.2017.01823/full.
Doyle T, Goujon C, Malim MH. HIV-1 and interferons: Who’s interfering with whom? Nat Rev Microbiol. 2015;13(7):403–13.
Article CAS PubMed PubMed Central Google Scholar
Bergantz L, Subra F, Deprez E, Delelis O, Richetta C. Interplay between intrinsic and innate immunity during HIV infection. Cells. 2019. https://doi.org/10.3390/cells8080922.
Article PubMed PubMed Central Google Scholar
Yin X, Langer S, Zhang Z, Herbert KM, Yoh S. Sensor sensibility—HIV-1 and the innate immune response. Cells. 2019;9:1–18.
Gingras SN, Tang D, Tuff J, McLaren PJ. Minding the gap in HIV host genetics: opportunities and challenges. Human Genet. 2020;139:865–75.
Touloumi G, Pantazis N, Babiker AG, Walker SA, Katsarou O, Karafoulidou A, et al. Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS. 2004;18(12):1697–705.
Article CAS PubMed Google Scholar
Ekenberg C, Tang MH, Zucco AG, Murray DD, MacPherson CR, Hu X, et al. Association between single-nucleotide polymorphisms in hla alleles and human immunodeficiency virus type 1 viral load in demographically diverse, antiretroviral therapy-naive participants from the strategic timing of antiretroviral treatment trial. J Infect Dis. 2019;220(8):1325–34.
Article CAS PubMed PubMed Central Google Scholar
MacArthur RD, Novak RM, Peng G, Chen L, Xiang Y, Hullsiek KH, et al. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 05. Lancet. 2006;368(9553):2125–35.
Article CAS PubMed Google Scholar
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. 2015. N Engl J Med. 373(9): 795–807. https://doi.org/10.1056/NEJMoa1506816
Murray DD, Grund B, Macpherson CR, Ekenberg C, Zucco AG, Reekie J, et al. Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV. AIDS. 2023;37(3):379–87.
Article CAS PubMed Google Scholar
Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2019. https://doi.org/10.1093/nar/gkz1031/5613674.
Article PubMed Central Google Scholar
Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50(D1):D687-92.
Article CAS PubMed Google Scholar
Hunt SE, McLaren W, Gil L, Thormann A, Schuilenburg H, Sheppard D, et al. Ensembl variation resources. Database. 2018. https://doi.org/10.1093/database/bay119/5255129.
Article PubMed PubMed Central Google Scholar
Cunningham F, Allen JE, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, et al. Ensembl. Nucleic Acids Res. 2022;50(D1):988–95.
Smedley D, Haider S, Ballester B, Holland R, London D, Thorisson G, et al. BioMart—biological queries made easy. BMC Genomics. 2009;10(1):22. https://doi.org/10.1186/1471-2164-10-22.
Article CAS PubMed PubMed Central Google Scholar
Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2013;44(8):955–9.
Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4(1):1–16.
Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods. 2013;10(1):5–6.
Article CAS PubMed Google Scholar
Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res. 2009;19(9):1655–64.
Article CAS PubMed PubMed Central Google Scholar
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904–9.
Article CAS PubMed Google Scholar
Kao PYP, Leung KH, Chan LWC, Yip SP, Yap MKH. Pathway analysis of complex diseases for GWAS, extending to consider rare variants, multi-omics and interactions. Biochim Biophys Acta Gen Subj. 2017;1861(2):335–53.
Article CAS PubMed Google Scholar
Lee J, Kim YJ, Lee J, Kim BJ, Lee S, Park T. Gene-set association tests for next-generation sequencing data. Bioinformatics. 2016;32(17):i611–9.
Article CAS PubMed PubMed Central Google Scholar
Lee S, Wu MC, Lin X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics. 2012;13(4):762–75. https://doi.org/10.1093/biostatistics/kxs014.
Article PubMed PubMed Central Google Scholar
Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet. 2011;89(1):82–93. https://doi.org/10.1016/j.ajhg.2011.05.029.
Comments (0)